Porous membrane
The porous membrane with a hydrophobic and hydrophilic polymer combination and specific structural features addresses the challenges of high filtration throughput and virus removal, achieving efficient antibody recovery and virus clearance in antibody-containing liquids.
Patent Information
- Application Number
- PCT/JP2024/018944
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-25
- Filing Date
- 2024-05-23
- Publication Date
- 2024-11-28
AI Technical Summary
Current virus removal membranes face challenges in achieving high filtration throughput for antibody-containing liquids due to hydrophobic interactions and struggle to maintain both safety and productivity, especially when dealing with small viruses like parvovirus, as they tend to block proteins and have low filtration throughput.
A porous membrane with a hydrophobic polymer and a water-insoluble hydrophilic polymer, featuring a dense layer with a specific pore structure and gradient index, which allows for efficient virus removal and high antibody recovery by minimizing pore clogging and maintaining high filtration efficiency.
The membrane achieves high filtration throughput for antibody-containing liquids while ensuring excellent virus removal performance, with a virus clearance rate of 5 or more and high protein recovery, effectively addressing the limitations of existing membranes.
Smart Images

Figure JP2024018944_28112024_PF_FP_ABST
Abstract
Description
porous membrane
[0001] The present invention relates to a porous membrane.
[0002] In recent years, treatment using plasma fractionated products and biopharmaceuticals has become widespread due to their low side effects and high therapeutic efficacy. However, because plasma fractionated products are derived from human blood and biopharmaceuticals are derived from animal cells, there is a risk of pathogenic substances such as viruses contaminating the pharmaceuticals.
[0003] To prevent viral contamination of pharmaceuticals, virus removal or inactivation is always performed. Methods for virus removal or inactivation include heat treatment, optical treatment, and chemical treatment. Due to issues such as protein denaturation, virus inactivation efficiency, and chemical contamination, membrane filtration methods that are effective against all viruses, regardless of their thermal and chemical properties, are attracting attention.
[0004] Examples of viruses to be removed or inactivated include polioviruses with diameters of 25 to 30 nm, the smallest of which is parvoviruses with diameters of 18 to 24 nm, and relatively large viruses such as HIV viruses with diameters of 80 to 100 nm. In recent years, there has been a growing need to remove small viruses, such as parvoviruses.
[0005] The primary performance required of a virus removal membrane is safety. Examples of safety include preventing contamination of plasma fraction preparations and biopharmaceuticals with pathogenic substances such as viruses, and preventing contamination with foreign substances such as eluates from the virus removal membrane. To prevent contamination with pathogenic substances such as viruses, it is important that the virus removal membrane sufficiently removes viruses. Non-Patent Document 1 states that the target clearance (LRV) for minute virus of mice and porcine parvovirus is 4, but in recent years, from the perspective of even greater safety against viruses, an LRV of 5 or higher has been desired. Furthermore, to prevent contamination with foreign substances such as eluates, it is important that no eluates are released from the virus removal membrane.
[0006] The second performance required of a virus removal membrane is productivity. Productivity refers to the efficient recovery of proteins such as albumin with a size of 5 nm and antibodies with a size of 10 nm. Ultrafiltration membranes and hemodialysis membranes with pore sizes of about several nm, as well as reverse osmosis membranes with even smaller pore sizes, are not suitable as virus removal membranes because proteins clog the pores during filtration. In particular, when the purpose is to remove small viruses such as parvovirus, it has been difficult to achieve both the above-mentioned safety and productivity because the size of the virus and the size of the protein are similar.
[0007] Patent Document 1 discloses a virus removal method using a membrane made of regenerated cellulose. Patent Document 2 discloses a virus removal membrane in which the surface of a membrane made of polyvinylidene fluoride (PVDF) formed by thermally induced phase separation is hydrophilized by graft polymerization. These membranes tend to have an overwhelmingly low filtration throughput of antibody-containing liquids due to the hydrophobic interaction of the antibody.
[0008] Furthermore, Patent Document 3 discloses a virus removal membrane having an initial virus logarithmic removal rate (LRV) of at least 4.0 against PhiX174, and a surface coated with hydroxyalkyl cellulose. 2 The present invention relates to an intrinsically hydrophobic polymeric membrane substrate with a throughput of over 1000 rpm.
[0009] Patent Document 4 discloses a virus removal membrane formed from a blend of a polysulfone polymer and polyvinylpyrrolidone (PVP). Patent Document 5 discloses a virus removal membrane formed from a blend of a polysulfone polymer and a copolymer of vinylpyrrolidone and vinyl acetate, and coated with a polysaccharide or a polysaccharide derivative. These membranes can efficiently separate and remove viruses contained in a solution, while at the same time allowing useful recovery substances such as proteins to efficiently pass through.
[0010] Patent Document 6 discloses a hollow fiber membrane made of polyethersulfone as a base material and a hydrophilic polymer as a coating layer. It can efficiently remove viruses contained in a protein solution, suppress high flux and flux reduction due to clogging during filtration, and highly efficiently recover proteins from virus-containing protein solutions. Patent Document 7 discloses a hollow fiber filtration membrane containing a polysulfone-based polymer and a hydrophilic polymer and having a gradient structure in which the pore size increases from the outer surface to the inner surface of the membrane. Even in the presence of relatively small impurities, such as protein aggregates, whose size is close to the size of the permeating active ingredient, the membrane can suppress the flux reduction over time during filtration and efficiently recover useful ingredients. Patent Document 8 discloses a hollow fiber filtration membrane containing a polysulfone-based polymer and a hydrophilic polymer and having a gradient asymmetric structure in which the average pore size of the pores increases from the outer surface to the inner surface. It suppresses protein adsorption to the pore surface of the dense layer during protein solution filtration and has excellent protein permeability. Patent Document 9 discloses a porous membrane with a gradient structure in which the average pore size of pores containing a hydrophobic polymer and a water-insoluble hydrophilic polymer increases from the downstream filtration portion to the upstream filtration portion. It is possible to recover useful components highly efficiently while suppressing clogging during protein solution filtration. Patent Document 10 discloses a porous hollow fiber membrane containing a polysulfone-based polymer and a hydrophilic polymer and having a dense layer in the central region of the membrane thickness. It is possible to remove viruses while suppressing a decrease in flux over time during protein solution filtration. Patent Document 11 discloses a porous membrane in which a hydrophilic polymer is coated on a hydrophobic polymer whose surface is defined by TOF-SIMS. It is possible to reduce the phenomenon of membranes sticking together during porous membrane production.
[0011] Patent Documents 3 to 11 describe that membranes containing a hydrophobic polymer and a hydrophilic polymer are excellent at removing viruses from protein solutions. However, there is no description whatsoever about the high filtration throughput of antibody-containing liquids due to the hydrophobic interaction of antibodies with these membranes.
[0012] Japanese Patent No. 4024041 Publication No. WO 2004 / 035180 Publication No. 4504963 Publication No. WO 2011 / 111679 Publication No. 5403444 Publication No. 6770807 Publication No. 6522001 Publication No. 6433513 Publication No. 6385444 Publication No. 6367977 Publication No. 7185766
[0013] PDA Journal of GMP and Validation in Japan, Vol. 7, No. 1, p. 44 (2005) Biotechnology and Bioengineering Vol. 118, p. 1105-1115 (2021) Biotechnology and Bioengineering Vol. 106, p. 627-637 (2010)
[0014] An object of the present invention is to provide a porous membrane that has a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of antibodies and has excellent virus removal performance.
[0015] As a result of extensive research and experimentation to solve the above problems, the inventors discovered that a porous membrane having a predetermined structure can solve the above problems, and thus completed the present invention.
[0016] That is, the present invention is as follows. [1] A porous membrane containing a hydrophobic polymer and a water-insoluble hydrophilic polymer, wherein the pore size / fiber size ratio at the outer surface of the porous membrane is 0.15 to 0.26, the long axis / short axis ratio of the pore circumscribing rectangle at the outer surface of the porous membrane is 1.00 to 1.60, the porous membrane has a dense layer, the proportion of pores of 10 nm or less in the dense layer is 8.0% or less, and the thickness of the dense layer is 1 to 8 μm. [2] The porous membrane according to [1], wherein the water-insoluble hydrophilic polymer is electrically neutral. [3] The porous membrane according to [1] or [2], wherein the hydrophobic polymer is a polysulfone-based polymer. [4] The porous membrane according to any of [1] to [3], wherein the water-insoluble hydrophilic polymer is a vinyl-based polymer. [5] The porous membrane according to any of [1] to [4], wherein the porous membrane has a gradient structure in which the pore size changes continuously from the outer surface of the porous membrane toward the liquid-contacting surface. [6] The porous membrane according to any one of [1] to [5], wherein the gradient index of the average pore size from the dense layer to the coarse layer is 0.5 to 12.0. [7] The porous membrane according to any one of [1] to [6], wherein the porous membrane is an ultrafiltration membrane. [8] The porous membrane according to any one of [1] to [7], wherein the porous membrane is a virus removal membrane. [9] The porous membrane according to any one of [1] to [8], wherein the porous membrane is a hollow fiber membrane or a tubular membrane.
[10] A filter comprising the porous membrane according to any one of [1] to [9].
[11] A method for producing a porous membrane, comprising: extruding a membrane-forming stock solution containing a hydrophobic polymer, a good solvent, and a non-solvent from a spinneret; and contacting a membrane outer surface coagulation liquid with the membrane-forming stock solution at the same linear speed as the membrane-forming stock solution extruded from the spinneret and parallel to the extrusion direction of the membrane-forming stock solution.
[12] A method for purifying an antibody, comprising: preparing a solution containing an antibody; and filtering the solution using the porous membrane according to any one of [1] to [9] to purify the antibody.
[0017] According to the present invention, it is possible to provide a porous membrane that has a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of antibodies and has excellent virus removal performance.
[0018] 1 is a diagram showing an example of image processing in the local thickness method according to an embodiment; 2 is a diagram showing an example of a maximum circle indicated in the local thickness method according to an embodiment; 3 is a diagram showing an example of a maximum circle indicated in the local thickness method according to an embodiment; 4 is a diagram showing an example of image processing according to an embodiment;
[0019] Hereinafter, an embodiment of the present invention (also referred to as "the present embodiment") will be described in detail. Note that the following is an example for explaining the present invention, and is not intended to limit the present invention to the following content. The present invention can be practiced with appropriate modifications within the scope of its gist.
[0020] One embodiment of the present invention relates to a porous membrane containing a hydrophobic polymer and a water-insoluble hydrophilic polymer, wherein the pore size / fiber size ratio on the outer surface of the porous membrane is 0.15 or more and 0.26 or less, the major axis / minor axis ratio of a circumscribed rectangle of a hole on the outer surface of the porous membrane is 1.00 or more and 1.60 or less, the porous membrane has a dense layer, the proportion of pores of 10 nm or less in the dense layer is 8.0% or less, and the thickness of the dense layer is 1 to 8 μm.
[0021] The porous membrane of this embodiment preferably has a filtration throughput of 4.0 kg or more and a viral clearance (LRV) of 5 or more when a solution at 25°C, adjusted with a buffer solution to give an antibody concentration of 15 mg / mL, is filtered through the porous membrane at an effective filtration pressure of 196 kPa for 3 hours to filter an antibody with high hydrophobicity.
[0022] [Composition of porous membrane] The porous membrane of this embodiment (hereinafter also referred to simply as "membrane") is mainly composed of a hydrophobic polymer and a water-insoluble hydrophilic polymer. Here, "mainly composed of a hydrophobic polymer and a water-insoluble hydrophilic polymer" means that the total of the hydrophobic polymer and the water-insoluble hydrophilic polymer accounts for 80% by mass or more of the materials constituting the porous membrane, preferably 90% by mass or more, more preferably 95% by mass or more, and even more preferably 100% by mass.
[0023] [Hydrophobic Polymer] Examples of hydrophobic polymers include polysulfone-based polymers, polyamides, polyimides, polyetherimides, polyphenylene ethers, and polyphenylene sulfides. Among these, aromatic polysulfone-based polymers are preferred. Examples of aromatic polysulfone-based polymers used in the present invention include those having repeating units represented by the following general formula (1) or general formula (2). In the formula, Ar preferably represents a disubstituted phenyl group, more preferably a disubstituted phenyl group at the para position. The degree of polymerization and molecular weight of the hydrophobic polymer compound are not particularly limited. -O-Ar-C(CH3)2-Ar-O-Ar-SO2-Ar- (1) -O-Ar-SO2-Ar- (2) The aromatic polysulfone-based polymers of the structures of general formulas (1) and (2) may contain functional groups, alkyl groups, or other substituents, and hydrogen atoms in the hydrocarbon skeleton may be substituted with other atoms or substituents, such as halogens. The polysulfone polymers may be used alone or in combination of two or more.
[0024] [Hydrophilic Polymer] In this embodiment, a hydrophilic polymer is one that forms a contact angle of 90 degrees or less when PBS (9.6 g of Dulbecco's PBS (-) powder "Nissui" commercially available from Nissui Pharmaceutical Co., Ltd. is dissolved in water to make a total volume of 1 L) on a polymer film. In this embodiment, the contact angle of the hydrophilic polymer is preferably 60 degrees or less, and more preferably 40 degrees or less. When a hydrophilic polymer with a contact angle of 60 degrees or less is contained, the porous film is easily wetted by water, and when a hydrophilic polymer with a contact angle of 40 degrees or less is contained, the tendency to become easily wetted by water is even more pronounced. The contact angle means the angle formed by the surface of a water droplet when a water droplet is dropped on the film surface, and is defined in JIS R3257.
[0025] [Water-insoluble hydrophilic polymer] In this embodiment, the water-insoluble hydrophilic polymer is a substance that satisfies the above-mentioned contact angle and elution rate. The water-insoluble hydrophilic polymer includes not only hydrophilic polymers that are themselves water-insoluble, but also water-soluble hydrophilic polymers that have been made water-insoluble in the manufacturing process. In other words, even if the water-soluble hydrophilic polymer is a substance that satisfies the above-mentioned contact angle, and is made water-insoluble in the manufacturing process so that the above-mentioned elution rate is satisfied in constant-pressure dead-end filtration after the filter is assembled, it is included in the water-insoluble hydrophilic polymer of this embodiment.
[0026] The porous membrane of this embodiment contains a water-insoluble hydrophilic polymer. From the viewpoint of preventing a rapid decrease in filtration rate due to membrane clogging caused by protein adsorption, the porous membrane of this embodiment is preferably hydrophilized by the presence of a water-insoluble hydrophilic polymer on the pore surfaces of the base membrane containing a hydrophobic polymer. Methods for hydrophilizing the base membrane include coating, grafting reaction, and crosslinking reaction after the formation of the base membrane made of a hydrophobic polymer.
[0027] [Vinyl Polymer] Examples of water-insoluble hydrophilic polymers include vinyl polymers. Examples of vinyl polymers include homopolymers of hydroxyethyl methacrylate, hydroxypropyl methacrylate, dihydroxyethyl methacrylate, diethylene glycol methacrylate, triethylene glycol methacrylate, polyethylene glycol methacrylate, vinylpyrrolidone, acrylamide, dimethylacrylamide, glucoxyethyl methacrylate, 3-sulfopropylmethacryloxyethyldimethylammonium betaine, 2-methacryloyloxyethyl phosphorylcholine, and 1-carboxydimethylmethacryloyloxyethylmethaneammonium; and homopolymers of styrene, ethylene, propylene, propyl methacrylate, butyl methacrylate, ethylhexyl methacrylate, and octadecyl methacrylate. Examples of the vinyl polymer include random copolymers, graft copolymers, and block copolymers of hydrophobic monomers such as acrylate, benzyl methacrylate, and methoxyethyl methacrylate with hydrophilic monomers such as hydroxyethyl methacrylate, hydroxypropyl methacrylate, dihydroxyethyl methacrylate, diethylene glycol methacrylate, triethylene glycol methacrylate, polyethylene glycol methacrylate, vinylpyrrolidone, acrylamide, dimethylacrylamide, glucoxyoxyethyl methacrylate, 3-sulfopropylmethacryloxyethyldimethylammonium betaine, 2-methacryloyloxyethyl phosphorylcholine, and 1-carboxydimethylmethacryloyloxyethylmethaneammonium. Examples of the vinyl polymer include copolymers of cationic monomers such as dimethylaminoethyl methacrylate and diethylaminoethyl methacrylate with anionic monomers such as acrylic acid, methacrylic acid, vinyl sulfonic acid, sulfopropyl methacrylate, and phosphooxyethyl methacrylate with the above-mentioned hydrophobic monomers, and may be polymers containing equal amounts of the anionic monomer and the cationic monomer so as to be electrically neutral.
[0028] [Electrically Neutral] The water-insoluble hydrophilic polymer is preferably electrically neutral from the viewpoint of preventing adsorption of proteins as solutes. In this embodiment, electrically neutral means that the molecule has no charge or that the molecule contains equal amounts of cations and anions.
[0029] Examples of water-insoluble hydrophilic polymers include polysaccharides such as cellulose and its derivatives such as cellulose triacetate. Polysaccharides and derivatives thereof also include crosslinked hydroxyalkyl cellulose and the like. Water-insoluble hydrophilic polymers may be polyethylene glycol and its derivatives, block copolymers of ethylene glycol and the above-mentioned hydrophobic monomers, or random or block copolymers of ethylene glycol and propylene glycol, ethylbenzyl glycol, or the like. One or both ends of polyethylene glycol and the above-mentioned copolymers may be substituted with hydrophobic groups to render them water-insoluble. Examples of polyethylene glycol compounds substituted with hydrophobic groups at one or both ends include α,ω-dibenzyl polyethylene glycol and α,ω-didodecyl polyethylene glycol. Also suitable are copolymers of polyethylene glycol and hydrophobic monomers such as dichlorodiphenyl sulfone, which have halogen groups at both ends of the molecule. Examples of water-insoluble hydrophilic polymers include polyethylene terephthalate, polyethersulfone, etc. obtained by condensation polymerization, in which hydrogen atoms in the main chain of polyethylene terephthalate, polyethersulfone, etc. are substituted with hydrophilic groups to make them hydrophilic. The hydrophilized polyethylene terephthalate, polyethersulfone, etc. may have hydrogen atoms in the main chain substituted with anionic groups or cationic groups, or may have equal amounts of anionic groups and cationic groups. Bisphenol A-type or novolac-type epoxy resins in which the epoxy groups have been ring-opened, or epoxy groups to which vinyl polymers, polyethylene glycol, etc. have been introduced, may also be silane-coupled. The water-insoluble hydrophilic polymers may be used alone or in combination of two or more.
[0030] As the water-insoluble hydrophilic polymer, from the viewpoint of ease of production, homopolymers of hydroxyethyl methacrylate, hydroxypropyl methacrylate, dihydroxyethyl methacrylate; and random copolymers of hydrophilic monomers such as 3-sulfopropylmethacryloxyethyldimethylammonium betaine, 2-methacryloyloxyethyl phosphorylcholine, and 1-carboxydimethylmethacryloyloxyethylmethaneammonium with hydrophobic monomers such as butyl methacrylate and ethylhexyl methacrylate are preferred. From the viewpoint of ease of selection of a solvent for the coating liquid when coating the water-insoluble hydrophilic polymer, and dispersibility and operability in the coating liquid, homopolymers of hydroxyethyl methacrylate and hydroxypropyl methacrylate; and random copolymers of hydrophilic monomers such as 3-sulfopropylmethacryloxyethyldimethylammonium betaine and 2-methacryloyloxyethyl phosphorylcholine with hydrophobic monomers such as butyl methacrylate and ethylhexyl methacrylate are more preferred.
[0031] Examples of water-soluble hydrophilic polymers that have been rendered water-insoluble during the membrane production process include those that have been made water-insoluble by coating a hydrophobic polymer base membrane with a water-soluble hydrophilic polymer obtained by copolymerizing a monomer having an azide group in its side chain with a hydrophilic monomer such as 2-methacryloyloxyethyl phosphorylcholine, followed by heat treatment to covalently bond the water-soluble hydrophilic polymer to the base membrane. Alternatively, a hydrophilic monomer such as 2-hydroxyalkyl acrylate may be graft-polymerized onto the hydrophobic polymer base membrane.
[0032] As shown in Non-Patent Documents 2 and 3, the filtration characteristics of virus removal membranes vary significantly depending on the type of antibody, even when a prefilter is used to remove impurities from a solution. This is thought to be due to differences in filtration performance depending on the hydrophobic interaction of the antibody, with the stronger the antibody's hydrophobic interaction, the lower the filtration performance. The present invention addresses the need to provide a porous membrane that has a high filtration throughput of antibody-containing liquids relative to the antibody's hydrophobic interaction and excellent virus removal performance. When a solution at 25°C adjusted with a buffer solution to an antibody concentration of 15 mg / mL is filtered through the porous membrane of this embodiment at an effective filtration pressure of 196 kPa for 3 hours, where A is the antibody's hydrophobic interaction and B is the filtration throughput of the antibody-containing solution, the relationship B = -62.59A + 84.68 ± 2.5 (1.01 ≦ A ≦ 1.25) is preferably satisfied. The porous membrane of this embodiment is suitable for filtering antibodies with a hydrophobic interaction of 1.01 to 1.25. The hydrophobic interaction is preferably 1.05 or more and 1.25 or less, more preferably 1.10 or more and 1.25 or less, and even more preferably 1.15 or more and 1.25 or less. When the value is equal to or less than the upper limit of the above formula (B = -62.59A + 84.68 + 2.5), the target virus clearance (LRV) tends to be improved. Furthermore, when the value is equal to or greater than the lower limit of the above formula (B = -62.59A + 84.68 - 2.5), the filtration throughput of the antibody-containing liquid due to the hydrophobic interaction of the antibody tends to be improved. There are no limitations on the antibody concentration, virus concentration, filtration temperature, filtration pressure, or filtration time. It is possible to purify an antibody by preparing a solution containing the antibody and filtering the solution using the porous membrane of this embodiment.
[0033] [Cross-sectional structure of porous membrane] The porous membrane of this embodiment preferably has a gradient structure in which the pore size continuously changes from the outer surface of the membrane to the liquid-contacting surface. Examples of gradient structures include, but are not limited to, a sponge structure in which the pore size continuously decreases from the outer surface of the membrane to the liquid-contacting surface (normal gradient structure), a sponge structure in which the pore size continuously decreases from the outer surface of the membrane to the smallest pore size layer and continuously increases from the smallest pore size layer to the liquid-contacting surface (reverse gradient structure), and a sponge structure in which the pore size continuously increases from the outer surface of the membrane to the liquid-contacting surface (reverse gradient structure). The gradient structure in which the pore size continuously changes in the cross-sectional structure of the porous membrane makes it possible to efficiently recover useful components such as antibodies while suppressing clogging during protein solution filtration. When considering the use of the porous membrane as a virus separation filtration membrane, the porous membrane of this embodiment preferably has a gradient structure with a smallest pore size layer (dense layer) in the downstream filtration portion of the membrane. In this specification, the term "dense layer" refers to a layer with an average pore size of 50 nm or less. In addition, a layer having an average pore size larger than 50 nm is a "coarse layer". In this embodiment, the downstream filtration portion refers to the range from the downstream filtration surface corresponding to one membrane surface to 10% of the membrane thickness, and the upstream filtration portion corresponding to the other membrane surface refers to the range from the upstream filtration surface to 10% of the membrane thickness. For example, in a porous hollow fiber membrane, if a liquid is passed through the outer surface, the range from the inner surface to 10% of the membrane thickness is the downstream filtration portion, and the range from the outer surface to 10% of the membrane thickness is the upstream filtration portion; if a liquid is passed through the inner surface, the range from the inner surface to 10% of the membrane thickness is the upstream filtration portion, and the range from the outer surface to 10% of the membrane thickness is the downstream filtration portion. In this embodiment, examples of the form of the porous membrane include a flat membrane, a hollow fiber membrane (hollow fiber membrane), and a tubular membrane.
[0034] The porous membrane of this embodiment is preferably a reverse gradient structure membrane having a dense layer in the downstream filtration region of the membrane, and has a gradient asymmetric structure in which the average pore size of the pores increases from the downstream filtration region to the upstream filtration region of the membrane, and the gradient index of the average pore size from the dense layer to the coarse layer is 0.5 to 12.0. In this embodiment, the dense layer of the porous membrane and the gradient index of the average pore size from the dense layer to the coarse layer are determined by photographing the membrane cross section using a scanning electron microscope (SEM). For example, the magnification is set to 50,000 times, and a field of view is set horizontally relative to the film thickness direction at any location on the membrane cross section. After photographing one set field of view, the field of view is moved horizontally relative to the film thickness direction, and the next field of view is photographed. This photographing operation is repeated to photograph the membrane cross section without any gaps, and the obtained photographs are combined to obtain a single membrane cross section photograph. In this cross-sectional photograph, the average pore diameter in a range (one field of view) of (2 μm in the direction perpendicular to the film thickness direction) × (1 μm from the downstream filtration surface toward the upstream filtration surface in the film thickness direction) is calculated every 1 μm from the downstream filtration surface toward the upstream filtration surface.
[0035] The average pore diameter is calculated using a method that uses image analysis. Specifically, Image-pro plus manufactured by MediaCybernetics is used to perform binarization of the pore and real portions. The pore and real portions are distinguished based on brightness, and any portions that could not be distinguished or noise are corrected using a freehand tool. The edge portions that form the outline of the pores and the porous structure observed deep inside the pores are identified as pores. After the binarization process, the area value of each pore is assumed to be a perfect circle, and the pore diameter is calculated. This is performed for all pores, and the average pore diameter is calculated for each 1 μm x 2 μm range. Note that pores that are interrupted at the edge of the field of view are also counted.
[0036] The gradient index of the average pore size from the dense layer to the coarse layer is calculated based on the field of view defined as the dense layer and the field of view of the coarse layer adjacent to the dense layer. The gradient index is calculated using a dense layer (first field) with an average pore size of 50 nm or less and a field of view (second field) of the coarse layer with an average pore size of more than 50 nm. Here, the first field and the second field are adjacent to each other. That is, when the average pore size increases from the downstream filtration portion of the membrane to the upstream filtration portion, the two fields in which the average pore size changes from 50 nm or less to more than 50 nm are the first field and the second field. Specifically, the gradient index of the average pore size from the dense layer with an average pore size of 50 nm or less to the coarse layer with an average pore size of more than 50 nm can be calculated using the following formula (1): Gradient index (nm / μm) of average pore size from dense layer to coarse layer = (average pore size (nm) of coarse layer (second visual field) having an average pore size of more than 50 nm - average pore size (nm) of dense layer (first visual field) having an average pore size of 50 nm or less) / 1 (μm) ... (1)
[0037] The virus removal mechanism in virus removal membranes is thought to be as follows: A solution containing viruses passes through a virus removal layer, which is made up of multiple layers of virus capture surfaces perpendicular to the permeation direction. There is always a distribution of pore sizes within these surfaces, and viruses are captured in pores smaller than the size of the viruses. In this case, the virus capture rate per surface is low, but by stacking multiple layers of these surfaces, high virus removal performance is achieved. For example, even if the virus capture rate per surface is 20%, by stacking 50 layers of these surfaces, the overall virus capture rate will be 99.999%. A large number of viruses are captured in areas where the average pore size is 50 nm or less.
[0038] For example, the molecular size of antibodies, which are the main physiologically active substances to be filtered, is approximately 10 nm, while the size of parvovirus is approximately 20 nm. The antibody solution, which is the filtration solution passed through the porous membrane, contains more impurities such as antibody aggregates than viruses. It is empirically known that even a slight increase in the amount of impurities in the protein solution significantly reduces flux. Blockage of the pores in the dense layer by impurities is one of the causes of a decrease in flux over time. In order to prevent impurities from blocking the pores in the dense layer, it is important to prevent impurities from penetrating the dense layer. Therefore, it is preferable to capture impurities in the gradient-structure layer before the protein solution permeates the dense layer. In order to capture as many impurities as possible in the gradient-structure layer before permeating the dense layer, it is preferable to increase the impurity capture capacity of the gradient-structure layer excluding the dense layer. Since a pore size distribution also exists on the permeation surface of the gradient-structure layer excluding the dense layer, if the gradient of the average pore size from the dense layer to the gradient-structure layer is gentle, the surface that can capture impurities increases, and the area of the layer that can capture impurities increases. Making the gradient of the average pore size from the dense layer to the coarse layer gentle is important for suppressing a decrease in flux due to impurities clogging the pores of the dense layer. In order to effectively capture impurities in the gradient-structure layer immediately before the dense layer, the gradient index of the average pore size from the dense layer to the coarse layer is preferably 0.5 to 12.0, more preferably 2.0 to 12.0, and even more preferably 2.0 to 10.0.
[0039] The porous membrane of the present embodiment is preferably an ultrafiltration membrane, and more preferably a virus removal membrane in which the proportion of pores of 10 nm or less in the dense layer, the thickness of the dense layer, the pore diameter / fiber diameter on the outer surface, and the major axis / minor axis of the pore circumscribed rectangle on the outer surface are as follows:
[0040] In this embodiment, for example, one of the causes of a decrease in flux over time is blockage of pores in the dense layer by antibody monomers, which are the most abundant component in the filtrate. Therefore, in order to prevent a decrease in flux, it is important to reduce the proportion of pores of 10 nm or less that can cause blockage by antibody monomers. However, simply increasing the average pore size to reduce the proportion of pores of 10 nm or less results in a thinner dense layer and reduced virus removal performance. To reduce the proportion of pores of 10 nm or less while maintaining virus removal performance, it is important to control the pore size distribution in the dense layer with an average pore size of 50 nm or less to reduce the proportion of pores of 10 nm or less in the dense layer. Based on the studies of the present inventors, in order to suppress blockage of pores by monomers while maintaining virus removal performance and achieve highly efficient protein recovery, it is preferable that the proportion of pores of 10 nm or less in the dense layer be 8.0% or less, and more preferably 5.0% or less. The percentage (%) of pores having a diameter of 10 nm or less in the dense layer refers to the average value calculated from the analysis of the SEM image using the following formula (2) over the entire field of view defined as the dense layer: (Total number of pores having a diameter of 10 nm or less in one field of view defined as the dense layer / Total number of pores in the same field of view) × 100 (2)
[0041] Flux, which refers to the permeation rate of the filtrate solution, is governed by the rate at which the solution permeates the dense layer, which is the region of the membrane with the smallest pore size. By suppressing pore clogging in the dense layer, it is possible to suppress the decrease in flux over time during filtration. Suppressing the decrease in flux over time during filtration leads to efficient recovery of proteins.
[0042] As described above, in a virus removal membrane, viruses are mainly captured in the region where the average pore size is 50 nm or less, so in order to increase the virus capture capacity, it is preferable to make the dense layer thicker. However, making the dense layer thicker reduces the protein flux. For example, in order to achieve highly efficient protein recovery, the thickness of the dense layer is preferably 1 to 8 μm, and more preferably 2 to 6 μm.
[0043] [Dense Layer with Low Pore Deformation] The present inventors have discovered that the "pore size / fiber diameter at the outer surface" and "major axis / minor axis of the pore circumscribed rectangle at the outer surface" of an inverted gradient structure membrane having a dense layer at the downstream filtration site of the membrane are extremely important for providing a porous membrane with a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody and excellent virus removal performance. In an inverted gradient structure membrane in which the outer surface of the porous membrane is a dense layer, or an inverted gradient structure membrane having a dense layer near the outer surface, the dense layer has a structure that reflects the structure of the outer surface. In the porous membrane manufacturing process from the time liquid-liquid phase separation is induced by contact between the membrane-forming solution and the non-solvent to the completion of phase separation (solidification), the outer surface of the porous membrane described below is manufactured as tension-free as possible, thereby allowing the present inventors to achieve a dense layer with low pore deformation in the dense layer.
[0044] [Pore size / fiber diameter at the outer surface of the porous membrane] The porous membrane of this embodiment preferably has a pore size / fiber diameter (pore size / fiber diameter J' described below) at the outer surface of 0.15 or more and 0.26 or less. By manufacturing the outer surface of the porous membrane as tensionless as possible, it is possible to reduce the pore size / fiber diameter at the outer surface. If the pore size / fiber diameter at the outer surface is less than 0.15, it is difficult to achieve the desired water permeability. If the pore size / fiber diameter at the outer surface is more than 0.26, it is difficult to obtain a virus removal membrane that has a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody.
[0045] [Major axis / minor axis of circumscribing rectangle of hole on outer surface of porous membrane] In the porous membrane of this embodiment, the major axis / minor axis of the circumscribing rectangle of hole on the outer surface (major axis / minor axis M'', described below) is preferably 1.00 or more and 1.60 or less. By manufacturing the outer surface of the porous membrane as tensionless as possible, it is possible to reduce the major axis / minor axis of the circumscribing rectangle of hole on the outer surface. If the outer surface of the porous membrane can be manufactured completely tensionless, the circumscribing rectangle of hole will be a circumscribing square of hole, and therefore the major axis / minor axis of the circumscribing rectangle of hole on the outer surface cannot theoretically be less than 1.00. If the major axis / minor axis of the circumscribing rectangle of hole on the outer surface exceeds 1.60, it is difficult to obtain a virus removal membrane that has a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody.
[0046] [Method for identifying the structure of a porous membrane] The pore characteristics, fiber diameter, and structural anisotropy (e.g., identification of pore deformation in a dense layer on or near the outer surface) in the outer surface structure of a porous membrane can be identified by the following method.
[0047] [Method for Obtaining an Image of the Outer Surface of a Porous Membrane] When the porous membrane is a hollow fiber membrane, the outer surface is fixed to the observation sample stage of a scanning electron microscope (SEM) with carbon paste. The prepared sample is osmium-coated using an osmium coater (HPC-30W, manufactured by Vacuum Device Co., Ltd.) with the applied voltage adjustment knob set to 4.5 and a discharge time of 3 seconds to prepare an observation sample. The observation sample is irradiated with an electron beam under the following conditions, and the viewing angle is adjusted so that the vertical direction of the image is parallel to the fiber length direction of the hollow fiber membrane. The contrast is adjusted using the automatic function in a field of view consisting only of the skeletal resin and pores. The magnification used for imaging is determined to be the magnification that can explain the outer surface pore size distribution, such that the largest pores in the vertical direction of the image are between 5 and 60, and the largest pores in the horizontal direction of the image are between 7 and 60. A backscattered electron image is obtained that is free of structural distortion and abnormal contrast due to charge buildup, and does not include the sample stage, carbon paste, or razor cut surface.
[0048] (SEM device conditions) SEM: Scanning electron microscope SU7000 manufactured by Hitachi High-Tech Corporation Probe current: Normal Acceleration voltage: 1 kV Working distance: 6 mm Detector: MD detector (backscattered electron image) Image size: 960 vertical x 1280 horizontal pixels
[0049] For one type of hollow fiber membrane, three lots of hollow fiber membranes are used, and SEM images (total of nine or more) from three or more fields of view without overlapping are obtained for each lot.
[0050] [Method for calculating fiber diameter F' on the outer surface of a porous membrane] The first analysis object image is analyzed using the filters.local_thickness function of the porespy (2.0.2) library of python (3.7.10) described in Reference 1 (Gostick et al., (2019). PoreSpy: A Python Toolkit for Quantitative Analysis of Porous Media Images. Journal of Open Source Software, 4 (37), 1296.) with the first argument being the first analysis object image and the second argument being mode = 'dt'. filter. The local_thickness function is a function that analyzes white pixels in the first analysis target image, so when the first analysis target image is analyzed, the fiber diameter (unit: pixel), which is the diameter of the resin skeleton, is calculated. The diameter (unit: pixel) is multiplied by the pixel resolution (unit: m / pixel) to obtain the diameter (unit: m). The total number of white pixels D 0 , the sum of all the obtained diameters E 0 Using this, the fiber diameter F in one SEM image can be expressed by the following formula (3): F = E 0 / D 0 (3)
[0051] Since a diameter is assigned to each pixel, F is a weighted average of the fiber diameters in the SEM image. For one type of hollow fiber membrane, the fiber diameter F is calculated using SEM images of at least three fields of view for each of three lots (a total of nine images). The number average of the fiber diameters F in all these SEM images is defined as the fiber diameter F' on the outer surface of the hollow fiber membrane.
[0052] Here, in the local thickness method used in the filters.local_thickness function, as shown in FIG. 1, the diameter is calculated by filling in the circles that fit into the area surrounded by the contour, starting from the largest. Therefore, as shown in FIG. 2, the area surrounded by the contour 500 into which the circle 501 can be placed does not have to be a circle. Also, as shown in FIG. 3, the area surrounded by the contour 502 does not have to be a closed area completely surrounded by line segments. It is possible to calculate the effective diameter used in filtration for fibers and membrane pores on the surface of porous membranes of various shapes. The same applies to the method using the filters.local_thickness function described below.
[0053] [Method for calculating pore diameter I' on the outer surface of a porous membrane] The first analysis target image is inverted to black and white, and the pixels that were white in the first analysis target image are turned black, and the pixels that were black in the first analysis target image are turned white to obtain a second analysis target image. Using the filters.local_thickness function of the porespy (2.0.2) library in Python (3.7.10) described in Reference 1, the first argument is the second analysis target image, and the second argument is mode = 'dt'. Since the filter.local_thickness function is a function that analyzes white pixels in the second analysis target image, when the second analysis target image is analyzed, the pore diameter (unit: pixel) is calculated. The diameter (unit: pixel) is multiplied by the pixel resolution (unit: m / pixel) to obtain the diameter (unit: m). Using the total number of white pixels G and the sum of all the diameters obtained H, the pore diameter I in one SEM image can be expressed by the following formula (4). Since a diameter is assigned to each pixel, the pore diameter I is a weighted average of the pore diameters in the SEM image. I = H / G (4)
[0054] For one type of hollow fiber membrane, SEM images of at least three fields of view for each of three lots (a total of nine images) are used to calculate the pore diameter I. The number average value of the pore diameters I of all these SEM images is defined as the pore diameter I' of the outer surface of the hollow fiber membrane.
[0055] [Calculation of pore diameter / fiber diameter J′ on the outer surface of the porous membrane] Using the pore diameter I and fiber diameter F in each SEM image, the pore diameter / fiber diameter ratio J is given by the following formula (5): J=I / F (5)
[0056] For one type of hollow fiber membrane, the pore size / fiber diameter ratio J is calculated using SEM images of at least three fields of view for each of three lots (a total of nine membranes). The number average value of the pore size / fiber diameter ratio J in all these SEM images is taken as the pore size / fiber diameter J' on the outer surface of the hollow fiber membrane. The ratio of the pore size to the fiber diameter on the outer surface of the porous membrane (pore size / fiber diameter) is a value obtained by normalizing the effective pore size for filtration using the fiber diameter.
[0057] [Calculation of the long diameter / short diameter M'' of the circumscribed rectangle of a hole present on the outer surface of a porous membrane] Independent white regions are extracted from the second image to be analyzed. For each extracted white region, the contour of each region is detected by extracting white pixels whose adjacent pixels in either the up, down, left, or right direction are black. As shown in Figure 4, of the rectangles circumscribed around this contour, taking rotation into consideration, the rectangle with the smallest area is determined to be the circumscribed rectangle. Of the four sides of the circumscribed rectangle, the length of the short side is the short diameter K and the length of the long side is the long diameter L. If this is the case, M, which represents the long diameter / short diameter of a certain contour, is given by the following equation (6): M = L / K (6)
[0058] M (major axis / minor axis) is calculated for all contours contained in one SEM image, and the number average value is defined as M'. M' is calculated using SEM images of at least three fields of view for each of three lots of one type of hollow fiber membrane (a total of nine images). The number average value of M' in all these SEM images is defined as the average value M'' of the major axis / minor axis of the pores present on the inner surface of the hollow fiber membrane. The ratio of the major axis to the minor axis of the pores on the outer surface of the porous membrane (major axis / minor axis) is an index of the anisotropy of the pores on the outer surface (for example, an index of the pore deformation of a dense layer on the outer surface, or a dense layer with a dense layer near the outer surface).
[0059] In this embodiment, the porous membrane is not particularly limited. For example, when the porous membrane is a porous hollow fiber membrane having a hollow fiber shape, it can be manufactured as follows. The following describes an example in which a polysulfone-based polymer is used as the hydrophobic polymer. For example, a polysulfone-based polymer, a solvent, and a non-solvent are mixed and dissolved, and the mixture is degassed to form a membrane-forming solution. This solution is simultaneously extruded from the annular portion and the center of a double-tube nozzle (spinneret) together with an internal coagulation liquid, and then introduced into a coagulation bath via the idle section to form a membrane. The resulting membrane is washed with water, wound up, drained from the hollow portion, heat-treated, and dried. It is then subjected to a hydrophilization treatment.
[0060] The solvent used for the membrane-forming solution can be a wide variety of solvents, as long as they are good solvents for polysulfone-based polymers, such as N-methyl-2-pyrrolidone (NMP), N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAc), dimethyl sulfoxide, and ε-caprolactam. However, amide-based solvents such as NMP, DMF, and DMAc are preferred, and NMP is more preferred.
[0061] It is preferable to add a non-solvent to the film-forming solution. Examples of non-solvents used in the film-forming solution include glycerin, water, alcohols, and diol compounds, with diol compounds being preferred. Diol compounds are a general term for compounds having hydroxyl groups at both ends of the molecule. Examples of diol compounds include diethylene glycol (DEG), triethylene glycol (TriEG), tetraethylene glycol (TetraEG), and polyethylene glycol (PEG).
[0062] Although the detailed mechanism is unknown, adding a non-solvent to the membrane-forming solution increases the viscosity of the solution, suppressing the diffusion rate of the solvent and non-solvent in the coagulation solution, thereby controlling coagulation and facilitating the control of a desirable structure for a porous membrane, which is suitable for forming a desired structure. The solvent / non-solvent ratio in the membrane-forming solution is preferably 40 / 60 to 80 / 20 by mass.
[0063] The concentration of the polysulfone polymer in the membrane-forming solution is preferably 15 to 35% by mass, more preferably 20 to 30% by mass, from the viewpoint of membrane strength and permeability.
[0064] The membrane-forming solution is obtained by dissolving a polysulfone polymer, a good solvent, and a non-solvent at a constant temperature while stirring. The temperature is preferably higher than room temperature, 30 to 80°C. Compounds containing tertiary or lower nitrogen (NMP, DMF, DMAc) are oxidized in air, and heating facilitates further oxidation. Therefore, the membrane-forming solution is preferably prepared in an inert gas atmosphere. Examples of inert gases include nitrogen and argon, with nitrogen being preferred from the viewpoint of production costs.
[0065] It is preferable to degas the membrane-forming solution from the viewpoint of preventing thread breakage during spinning and suppressing the formation of macrovoids after membrane formation. The degassing step can be performed as follows: The pressure inside a tank containing the completely dissolved membrane-forming solution is reduced to 2 kPa and the solution is allowed to stand for at least one hour. This operation is repeated seven times or more. To improve the degassing efficiency, the solution may be stirred during degassing.
[0066] It is preferable to remove foreign matter from the membrane-forming solution before it is discharged from the spinneret. Removing foreign matter can prevent thread breakage during spinning and control the structure of the membrane. In order to prevent foreign matter from being mixed in through the packing of the membrane-forming solution tank, it is preferable to install a filter before the membrane-forming solution is discharged from the spinneret. Filters with different pore sizes may be installed in multiple stages, and are not particularly limited. For example, it is preferable to install a mesh filter with a pore size of 30 μm and a mesh filter with a pore size of 10 μm, in that order, from the side closest to the membrane-forming solution tank.
[0067] It is preferable to use the same components as those used in the membrane-forming stock solution and the coagulation solution as the internal coagulation solution used during membrane formation. For example, if NMP / TriEG is used as the solvent / non-solvent for the membrane-forming stock solution and NMP / TriEG-water is used as the solvent / non-solvent for the coagulation solution, the internal coagulation solution is preferably composed of NMP-TriEG-water. When the amount of solvent in the internal coagulation solution is large, it has the effect of delaying the progress of coagulation and slowly progressing the formation of a membrane structure, and when the amount of non-solvent is large, it has the effect of slowing the diffusion of the solution due to the thickening effect, slowing the progress of coagulation and slowly progressing the formation of a membrane structure, and when the amount of water is large, it has the effect of accelerating the progress of coagulation. In order to allow the coagulation to proceed appropriately, neither too quickly nor too slowly, to control the membrane structure, and to obtain a porous hollow fiber membrane having a membrane structure preferable as a filtration membrane, it is preferable to use approximately equal amounts of the solvent and non-solvent, which are organic components in the internal coagulation liquid, and it is preferable that the ratio of the solvent / non-solvent, which are organic components in the internal coagulation liquid, is 35 / 65 to 65 / 35 in weight ratio, and the ratio of the organic component / water is 70 / 30 to 100 / 0 in mass ratio.
[0068] The spinneret temperature is preferably 25 to 50°C to obtain an appropriate hole diameter. After being discharged from the spinneret, the membrane-forming solution passes through the free-running section and is introduced into the coagulation bath. The residence time in the free-running section is preferably 0.02 to 0.6 seconds. By setting the residence time to 0.02 seconds or more, sufficient coagulation can be achieved before introduction into the coagulation bath, resulting in an appropriate hole diameter. By setting the residence time to 0.6 seconds or less, excessive coagulation can be prevented, enabling precise control of the membrane structure in the coagulation bath.
[0069] The inventors have achieved a dense layer with low pore deformation in the dense layer by producing the outer surface of a porous membrane as tension-free as possible during the porous membrane production process from the time liquid-liquid phase separation is induced by contact between the membrane-forming solution and a non-solvent to the completion of phase separation (coagulation). In conventional methods, the membrane-forming solution passes through a filter and a spinneret, is moderately coagulated in the idling section, and then is introduced into a coagulation bath. Liquid-liquid phase separation is induced in the membrane-forming solution by contact with a non-solvent in the internal coagulation solution. When a membrane in a state where liquid-liquid phase separation has been induced and coagulation has not yet been completed is introduced into a typical coagulation bath containing only a coagulation solution, a stretching force (tension) is applied to the membrane due to bath resistance and frictional resistance caused by contact with the rolls in the coagulation bath, which tends to cause pore deformation in the dense layer on the outer surface or in the dense layer near the outer surface.
[0070] On the other hand, in the present invention, before the membrane is introduced into the coagulation bath, the outer surface of the membrane is brought into contact with a coagulation liquid (referred to as an "external coagulation liquid") that moves in the same direction as the membrane's movement (i.e., parallel to the membrane's movement direction), thereby reducing the tension acting on the outer surface of the membrane and thereby suppressing pore deformation on the outer surface of the membrane. In this manner, the liquid exchange at the interface of the outer surface of the membrane is carried out very slowly, and coagulation proceeds slowly.
[0071] A specific example of tensionless production is a method in which an external coagulation liquid is flowed through a tube in the same direction as the membrane-forming solution while the membrane-forming solution is being discharged into the tube. Note that an air gap exists between the spinneret that discharges the membrane-forming solution and the tube.
[0072] The smaller the difference between the moving speed (linear speed) of the membrane-forming solution discharged from the spinneret and the moving speed (linear speed) of the external coagulation liquid, the more the tension at the time of contact can be reduced. Therefore, the difference between the linear speed of the membrane-forming solution and the linear speed of the external coagulation liquid is preferably within ±12%, more preferably within ±10%, and even more preferably within ±5%. In this specification, when the difference is within ±12%, it is expressed as "the same linear speed."
[0073] In order to suppress pore deformation on the outer surface of the membrane, it is also preferable to slow down the spinning speed, which is preferably 2 m / min or less, and from the viewpoint of productivity, preferably 0.1 m / min or more and 2 m / min or less.
[0074] The draft ratio ([take-up speed] / [linear extrusion speed of the membrane-forming solution]) is preferably 1.1 to 6, more preferably 1.1 to 4, and even more preferably 1.1 to 2. When no stretching is applied between the take-up machine and the winder, the take-up speed is synonymous with the spinning speed.
[0075] The moving direction of the membrane (the direction in which the membrane-forming solution is discharged) and the moving direction of the external coagulation solution are preferably both vertical (i.e., the direction of gravity).
[0076] The outer surface of the membrane is preferably kept in contact with the external coagulation liquid until phase separation (coagulation) is complete. The contact time is preferably 5 to 180 seconds, more preferably 10 to 150 seconds, and even more preferably 20 to 120 seconds.
[0077] A preferred production method is, for example, a method in which the spinning speed is 2 m / min or less, and an external coagulation liquid (membrane outer surface coagulation liquid) is brought into contact with the membrane-forming dope at the same linear speed as the membrane-forming dope discharged from the spinneret, parallel to the direction of discharge from the spinneret, from the time when liquid-liquid phase separation is induced by contact between the membrane-forming dope and the internal coagulation liquid until the phase separation is completed. In the present invention, by appropriately setting the difference between the moving speed of the membrane-forming dope discharged from the spinneret and the moving speed of the external coagulation liquid, the spinning speed, and the draft ratio, the tension applied to the membrane from the time when the membrane-forming dope is discharged from the spinneret to the time when coagulation is completed is reduced, thereby suppressing pore deformation in the dense layer on the outer surface and in the dense layer near the outer surface, and making it possible to produce a virus removal membrane with a high filtration throughput of antibody-containing liquid due to hydrophobic interactions.
[0078] The external coagulation liquid used in membrane formation preferably contains the same components as those used in the membrane-forming solution and the internal coagulation liquid. Since the organic component has the effect of delaying coagulation and water has the effect of accelerating coagulation, the external coagulation liquid preferably has a solvent / non-solvent ratio of the organic component of 35 / 65 to 65 / 35 by mass, and an organic component / water ratio of 90 / 10 to 50 / 50 by mass, more preferably 60 / 40 to 40 / 60 by mass.
[0079] Here, the spinning speed (spinning rate) refers to the winding speed in a series of hollow fiber membrane production processes, in which the membrane-forming solution discharged from the spinneret together with the internal coagulation liquid passes through an air gap, and the external coagulation liquid is brought into contact with the membrane-forming solution parallel to the direction of discharge from the spinneret at the same linear speed as the membrane-forming solution discharged from the spinneret, from the time when liquid-liquid phase separation is induced by contact between the membrane-forming solution and the internal coagulation liquid until the phase separation is completed, and the membrane that has passed through a coagulation bath is wound up, without any stretching operation. Furthermore, if the air gap is surrounded by a cylindrical tube or the like and a gas having a constant temperature and humidity is flowed through the air gap at a constant flow rate, hollow fiber membranes can be produced in a more stable state.
[0080] Generally, when the concentration of the membrane-forming raw material in the stock solution decreases, the temperature of the stock solution increases, the concentration of the good solvent in the internal coagulation liquid decreases, or the temperature of the internal coagulation liquid increases, the pore size increases, the FLUX increases, but the LRV decreases. Furthermore, weakening the coagulation force during membrane formation, for example by adding a poor solvent with weak coagulation force to the stock solution or by adding a good solvent to the external coagulation liquid, thickens the dense layer, decreases the FLUX, but increases the LRV. Thus, by optimizing various membrane-forming conditions and forming the membrane without tension, it is possible to produce a virus removal membrane with a membrane structure that combines filtration and virus removal properties.
[0081] The hollow fiber membranes removed from the coagulation bath are washed with warm water. In the water-washing step, it is preferable to completely remove the residual solvent and non-solvent. If the hollow fiber membranes are dried while still containing the solvent, the solvent may concentrate within the membrane during drying, dissolving or swelling the polysulfone-based polymer, potentially changing the membrane structure. In order to increase the diffusion rate of the solvent and non-solvent to be removed and to improve the efficiency of water washing, the temperature of the warm water is preferably 50°C or higher. A Nelson roller is preferably used in the water-washing step. In order to thoroughly wash the hollow fiber membranes, the residence time in the water-washing bath is preferably 80 to 300 seconds. The longer the water-washing step aimed at removing unnecessary components, the better, but from the viewpoint of production efficiency, it is appropriate to keep it to 300 seconds or less.
[0082] The hollow fiber membranes are pulled out of the washing bath, pass through a take-up machine, and then wound into a reel by a winding machine. If the hollow fiber membranes are wound in air, they gradually dry and shrink slightly. The degree of shrinkage of the membranes differs between the early and late stages of winding, resulting in different membrane structures and causing non-uniformity in the hollow fiber membranes obtained in the production process. To obtain a uniform membrane, it is preferable to wind the hollow fiber membranes in water.
[0083] The hollow fiber membrane wound on a skein is cut at both ends so that the length is 60 cm or less, bundled, and held on a support to prevent slack. The held hollow fiber membrane is then washed in a hot water treatment process after a water washing process in which water is passed through the hollow fibers. A cloudy liquid containing suspended nanometer- to micrometer-sized polysulfone-based polymer particles remains in the hollow portion of the hollow fiber membrane wound on a skein. Drying the hollow fiber membrane without removing the cloudy liquid can result in the polysulfone-based polymer particles clogging the pores of the hollow fiber membrane and reducing membrane performance, so it is preferable to remove the cloudy liquid from the hollow portion. The hot water treatment process efficiently removes particles and other particles that were not completely removed in the water washing process. The hot water temperature is preferably 50 to 100°C. A hot water temperature of 50°C or higher is preferred because it increases cleaning efficiency. The cleaning time is preferably 30 to 120 minutes. It is preferable to change the hot water several times during cleaning.
[0084] The membrane from which the fine particles have been removed is preferably subjected to high-pressure hot water treatment. Specifically, the membrane is completely immersed in water, placed in a high-pressure steam sterilizer, and treated at 120°C or higher for 2 to 6 hours. Although the detailed mechanism is unknown, high-pressure hot water treatment not only completely removes any traces of solvent and non-solvent remaining in the membrane, but also optimizes the entanglement and state of existence of the polysulfone-based polymer in the dense layer region.
[0085] In view of ease of filter processing, the inner diameter of the porous membrane is preferably 200 to 400 μm, and the membrane thickness is preferably 30 to 80 μm.
[0086] The hollow fiber membranes are used after being molded into filters. In the initial process of filter molding, bundled hollow fiber membranes are used.
[0087] The base membrane (porous membrane before coating) undergoes a coating process to become the porous membrane of this embodiment. For example, when hydrophilization treatment is performed by coating, the coating process consists of a process of immersing the base membrane in a coating liquid, a process of draining the immersed base membrane, and a process of drying the drained base membrane. In the immersion process, the base membrane is immersed in a hydrophilic polymer solution. The solvent of the coating liquid is a good solvent for the hydrophilic polymer and is not particularly limited as long as it is a poor solvent for polysulfone-based polymers, but alcohol is preferred. The concentration of the water-insoluble hydrophilic polymer in the coating liquid is preferably 1.0% by mass or more from the viewpoint of sufficiently coating the pore surface of the base membrane with the hydrophilic polymer and suppressing a decrease in flux over time due to protein adsorption during filtration, and preferably 10.0% by mass or less from the viewpoint of coating with an appropriate thickness and preventing the pore size from becoming too small and causing a decrease in flux. The immersion time of the base membrane in the coating liquid is preferably 8 to 24 hours.
[0088] In the dewatering step, excess coating solution adhering to the hollow and outer periphery of the substrate membrane immersed in the coating solution for a predetermined time is removed by centrifugation. From the viewpoint of preventing adhesion of the membranes to each other after drying due to the remaining hydrophilic polymer, it is preferable to set the centrifugal force during the centrifugation to 10 G or more and the centrifugation time to 30 minutes or more.
[0089] The present embodiment will be described in detail below with reference to examples, but the present invention is not limited to these examples. Measurement methods shown in the examples are as follows. The pore diameter / fiber diameter on the outer surface, the major axis / minor axis of the circumscribing rectangle of the pores on the outer surface, the proportion of pores of 10 nm or less in the dense layer, and the gradient index of the average pore diameter from the dense layer to the coarse layer were measured by the methods described above.
[0090] (1) Measurement of inner diameter and membrane thickness The inner diameter of the porous hollow fiber membrane was determined by photographing the vertical cut cross section of the membrane with a stereomicroscope. The outer diameter was determined in the same manner as the inner diameter, and the membrane thickness was calculated by (outer diameter - inner diameter) / 2. The membrane area was calculated from the inner diameter and the effective length of the hollow fiber membrane.
[0091] (2) Measurement of the permeation rate of pure water. The effective membrane area is 3.3 cm 2 The filter was assembled so as to have a filtration rate of 1.0 bar, and the amount of pure water filtered at 25° C. was measured by dead-end filtration at a constant pressure of 1.0 bar. The amount of water permeated was calculated from the filtration time.
[0092] (3) Thickness of dense layer The cross section of the hollow fiber was photographed using a scanning electron microscope (SEM) with an acceleration voltage of 1 kV and a magnification of 50,000 times, with the field of view set horizontally to the membrane thickness direction at any location on the cross section of the hollow fiber. After photographing one set field of view, the field of view was moved horizontally to the membrane thickness direction, and the next field of view was photographed. This photographing operation was repeated to photograph the membrane cross section without gaps, and the resulting photographs were combined to obtain a single membrane cross-sectional photograph. In this cross-sectional photograph, the average pore diameter was calculated in the range of (2 μm in the circumferential direction of the membrane) × (1 μm from the outer surface toward the inner surface). The average pore diameter was calculated using an image analysis method. Using Image-pro plus manufactured by MediaCybernetics, the void portion and the solid portion were distinguished based on brightness. Unidentifiable areas and noise were corrected using a freehand tool, and the edge portions that form the outline of the pores and the porous structure observed deep inside the pores were identified as pores. After binarization, the area value of each pore was assumed to be a perfect circle, and the diameter of the pores was calculated to two significant digits. This was performed for all pores, and the average pore diameter was calculated for each 1 μm x 2 μm range. Pores that were interrupted at the edge of the field of view were also counted. Fields with an average pore diameter of 50 nm or less were considered to be dense layers, and the thickness of the dense layer was calculated as "the number of images showing an average pore diameter of 50 nm or less x 1 μm."
[0093] (4) Protein filtration test Effective membrane area: 3.3 cm 2 The assembled filter was subjected to autoclaving at 122°C for 60 minutes. The cumulative filtration volume of protein was determined by the following experiment. A monoclonal antibody with a HIC (hydrophobic interaction) value of 1.25 and an isoelectric point of 7.0 was filtered at 2.0 bar for 3 hours at a constant pressure of 2.0 bar at pH 5.5, 100 mM acetate-sodium hydroxide buffer, and 200 mM sodium chloride, to a concentration of 15 mg / mL. The cumulative protein recovery volume was calculated from the filtrate recovery volume, the protein concentration of the filtrate, and the membrane area of the filter. The protein used for filtration was a formulation purchased for research use. In this test, a high filtration volume was defined as a protein throughput of 4.0 kg or more.
[0094] (5) Viral Clearance Measurement The solution prepared in "(4) Protein Filtration Test" was spiked with 0.5% by volume of minute virus of mice (MVM) solution to prepare a filtrate. The prepared filtrate was filtered at a dead end at a constant pressure of 2.0 bar for 180 minutes. The titer (TCID50 value) of the filtrate was measured by virus assay. The viral clearance of PPV was calculated by LRV = Log(TCID50) / mL(filtrate) - Log(TCID50) / mL(filtrate). In this measurement, an LRV of 5 or more was considered to be a high level of virus removal.
[0095] (6) Elution Evaluation The filter prepared in the same manner as in (4) above was subjected to constant-pressure dead-end filtration at 2.0 bar to filter 100 mL of pure water at 25°C, and the filtrate was recovered and concentrated. The carbon content of the resulting concentrate was measured using a total organic carbon meter TOC-L (Shimadzu Corporation), and the elution rate from the membrane was calculated.
[0096] (7) Measurement of antibody hydrophobic interaction (HIC) The HPLC system used was an ACQUITY UPLC H-Class Bio system (Waters), the column used was an ACQUITY TSKgel Butyl-NPR Column (Waters), and the detector used was an ultraviolet-visible detector (280 nm). 2 M ammonium sulfate aqueous solution, 0.04 M phosphate buffer (pH 7.0), and ultrapure water were used as the eluent. The HIC value was determined as the retention time ratio when the retention time of Venoglobulin IH 5% Intravenous Injection (commercially available from Mitsubishi Tanabe Pharmaceuticals) was set to 1. In this measurement, proteins with an HIC value of 1.01 or more were considered to be highly hydrophobic antibodies.
[0097] [Example 1] 24 parts by mass of PES (ULTRASON (registered trademark) E6020P manufactured by BASF), 36 parts by mass of NMP (manufactured by Kishida Chemical Co., Ltd.), and 40 parts by mass of TriEG (manufactured by Kanto Chemical Co., Ltd.) were mixed at 35°C, and the mixture was degassed under reduced pressure at 2 kPa seven times to prepare a solution used for membrane formation. This membrane-forming solution was maintained at 35°C and discharged from a spinneret (double annular nozzle, nozzle temperature 35°C, temperature of the membrane-forming solution at the nozzle 35°C, temperature of the internal coagulation solution 35°C) together with an internal coagulation solution consisting of 75 parts by mass of NMP and 25 parts by mass of water (water content 25% by weight). The solution was then passed through a sealed 30 mm air gap, and an external coagulation solution (temperature 20°C) consisting of 25 parts by mass of NMP and 75 parts by mass of water was contacted with the membrane-forming solution for 2 m parallel to the direction of discharge from the spinneret at the same linear speed as the membrane-forming solution discharged from the spinneret (traveling 2 m with the external coagulation solution inside a 1.0 cm diameter tube), and then introduced into a coagulation bath containing a coagulation solution consisting of 25 parts by mass of NMP and 75 parts by mass of water at 20°C. The spinning speed was 1.5 m / min. It was confirmed that phase separation was complete by contacting the membrane-forming solution with the external coagulation solution for 2 m parallel to the direction of discharge from the spinneret. The draft ratio (the ratio between the spinning speed and the linear velocity of the membrane-forming solution discharged from the spinneret) was set to 2. The membrane drawn out from the coagulation bath was run through a Nelson roll in a water washing bath set at 55 ° C, and then wound up using a reel in water. The wound membrane was cut at both ends of the reel, bundled, held on a support to prevent loosening, and immersed in 80 ° C hot water for 60 minutes. The washed membrane was subjected to high-pressure hot water treatment at 128 ° C for 3 hours, and then vacuum dried to obtain a hollow fiber-shaped substrate membrane. The obtained hollow fiber-shaped substrate membrane was immersed in a coating solution of 2.5 parts by mass of polyhydroxyethyl methacrylate (PHEMA) (produced using hydroxyethyl methacrylate (Kanto Chemical Co., Ltd.)) having a weight average molecular weight of 80 kDa and 97.5 parts by mass of methanol for 24 hours, and then centrifuged at 12.5 G for 30 minutes. After centrifugal dewatering, it was vacuum dried for 18 hours to obtain a hollow fiber-shaped porous membrane. The performance of the obtained porous membrane is shown in Table 1. It was confirmed that the membrane had a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody and excellent virus removal performance.
[0098] [Example 2] The same procedure as in Example 1 was carried out, except that the draft ratio was set to 1.2. The performance of the obtained porous membrane is shown in Table 1 below. It was confirmed that the membrane had a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody and excellent virus removal performance.
[0099] [Example 3] The same procedure as in Example 1 was carried out, except that the draft ratio was set to 4. The performance of the obtained porous membrane is shown in Table 1 below. It was confirmed that the membrane had a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody, and also had excellent virus removal performance.
[0100] Example 4 The same procedure as in Example 1 was repeated, except that an external coagulation liquid (temperature 15°C) consisting of 15 parts by mass of NMP and 85 parts by mass of water was brought into contact with the membrane-forming solution for 2 m parallel to the direction of discharge from the spinneret at the same linear speed as the membrane-forming solution discharged from the spinneret (traveling 2 m together with the external coagulation liquid through a 1.0 cm diameter tube), and then introduced into a coagulation bath containing a coagulation liquid consisting of 15 parts by mass of NMP and 85 parts by mass of water at 15°C. By bringing the membrane-forming solution and the external coagulation liquid into contact for 2 m parallel to the direction of discharge from the spinneret, it was confirmed that phase separation was complete. The performance of the obtained porous membrane is shown in Table 1 below. It was confirmed that the membrane had a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody and excellent virus removal performance.
[0101] Example 5 The membrane-forming solution was maintained at 40°C and discharged from a spinneret (double annular nozzle, nozzle temperature 40°C, membrane-forming solution temperature at the nozzle 40°C, internal coagulation solution temperature 40°C) together with an internal coagulation solution consisting of 74 parts by weight of NMP and 26 parts by weight of water (water content 26 wt%). The membrane-forming solution was then passed through a sealed 30 mm air gap. An external coagulation solution (temperature 18°C) consisting of 45 parts by weight of NMP and 55 parts by weight of water was then contacted with the membrane-forming solution for 2 m parallel to the direction of discharge from the spinneret (traveling 2 m inside a 1.0 cm diameter tube together with the external coagulation solution), and then introduced into a coagulation bath containing a coagulation solution consisting of 45 parts by weight of NMP and 55 parts by weight of water at 18°C. The procedure was the same as in Example 1. The completion of phase separation was confirmed by contacting the membrane-forming solution with the external coagulation solution for 2 m parallel to the direction of discharge from the spinneret. The properties of the resulting porous membrane are shown in Table 1 below. It was confirmed that the membrane has a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody, and has excellent virus removal performance.
[0102] Comparative Example 1 The same procedure as in Example 1 was repeated, except that the spinning speed was 4 m / min, the draft ratio was 10, and the air gap was 80 mm. The performance of the obtained porous membrane is shown in Table 1 below. The outer surface and dense layer of the porous membrane did not have an appropriate structure, resulting in a decrease in virus removal performance.
[0103] Comparative Example 2 The membrane-forming solution was maintained at 25°C and discharged from a spinneret (double annular nozzle, nozzle temperature 25°C, membrane-forming solution temperature at the nozzle 25°C, internal coagulation solution temperature 25°C) together with an internal coagulation solution consisting of 73 parts by weight of NMP and 27 parts by weight of water (water content 27% by weight). The membrane-forming solution was passed through a sealed 30 mm air gap, and an external coagulation solution consisting of 10 parts by weight of NMP and 90 parts by weight of water (temperature 15°C) was contacted with the membrane-forming solution for 2 m parallel to the direction of discharge from the spinneret (traveling 2 m inside a 1.0 cm diameter tube together with the external coagulation solution). The procedure was the same as in Example 1, except that the membrane-forming solution was then introduced into a coagulation bath containing a coagulation solution consisting of 10 parts by weight of NMP and 90 parts by weight of water at 15°C. It was confirmed that phase separation was complete by contacting the membrane-forming solution with the external coagulation solution for 2 m parallel to the direction of discharge from the spinneret. The performance of the resulting porous membrane is shown in Table 1 below. Since the dense layer thickness was less than 1 μm, the virus removal performance was reduced.
[0104] Comparative Example 3 24 parts by mass of PES (ULTRASON (registered trademark) E6020P manufactured by BASF), 30.4 parts by mass of NMP (manufactured by Kishida Chemical Co., Ltd.), 5 parts by mass of water, 33.6 parts by mass of TriEG (manufactured by Kanto Chemical Co., Inc.), and 12 parts by mass of a copolymer of vinylpyrrolidone and vinyl acetate (Luviskol (registered trademark) VA64 manufactured by BASF, hereinafter referred to as "VA64") were mixed at 50°C, and the mixture was degassed under reduced pressure at 2 kPa seven times to obtain a solution used as a membrane-forming solution. This membrane-forming solution was maintained at 30°C, and together with an internal coagulation liquid (water content 5 wt%) consisting of 52.8 parts by mass of NMP, 42.2 parts by mass of TriEG, and 5 parts by mass of water, it was extruded from a spinneret (double annular nozzle, nozzle temperature 30°C, temperature of the membrane-forming solution at the nozzle 30°C, temperature of the internal coagulation liquid 30°C), and passed through a sealed 80 mm air gap. At the same linear speed as the membrane-forming solution extruded from the spinneret, an external coagulation liquid (temperature 30°C) consisting of 38.9 parts by mass of NMP, 31.1 parts by mass of TriEG, and 30 parts by mass of water was contacted with the membrane-forming solution for 2 m (traveling 2 m with the external coagulation liquid in a 1.0 cm diameter tube), parallel to the direction of extrusion from the spinneret, and then introduced into a coagulation bath containing a coagulation liquid consisting of 38.9 parts by mass of NMP, 31.1 parts by mass of TriEG, and 30 parts by mass of water at 30°C. The spinning speed was 20 m / min. The completion of phase separation was confirmed by contacting the membrane-forming solution and the external coagulation solution for 2 m parallel to the direction of extrusion from the spinneret. The draft ratio was 2. The membrane drawn out from the coagulation bath was run through a water washing bath set at 55 ° C on a Nelson roll, and then wound up using a reel in water. The wound membrane was cut at both ends of the reel, bundled, held on a support to prevent slack, and immersed in hot water at 80 ° C for 60 minutes. The washed membrane was subjected to high-pressure hot water treatment at 128 ° C for 3 hours, followed by vacuum drying to obtain a hollow fiber-shaped substrate membrane. The obtained hollow fiber-shaped substrate membrane was immersed in a coating solution of 2.5 parts by mass of polyhydroxyethyl methacrylate (produced using hydroxyethyl methacrylate (Kanto Chemical Co., Ltd.)) with a weight average molecular weight of 80 kDa and 97.5 parts by mass of methanol for 24 hours, and then centrifuged at 12.5 G for 30 minutes. After centrifugal dewatering, the mixture was vacuum dried for 18 hours to obtain a hollow fiber porous membrane. The performance of the obtained porous membrane is shown in Table 1 below.The thickness of the outer surface of the porous membrane and the dense layer was inappropriate, resulting in a low protein throughput.
[0105] Comparative Example 4 The same procedure as in Example 3 was repeated, except that the discharged membrane-forming solution was brought into contact with the coagulation solution at a distance of 2 m in a 300 L coagulation solution layer without flow (i.e., the membrane-forming solution and the external coagulation solution were not brought into contact at the same linear speed). The performance of the obtained porous membrane is shown in Table 1 below. The pore diameter / fiber diameter and the major axis / minor axis of the pore circumscribed rectangle on the outer surface of the porous membrane increased, resulting in a decrease in protein processing capacity.
[0106] Comparative Example 5 The same procedure as in Example 1 was carried out except that the external coagulation liquid temperature and the coagulation liquid temperature were set to 25°C, the spinning speed was set to 5 m / min, and the draft ratio was set to 2. The pore size / fiber diameter ratio and the major axis / minor axis ratio on the outer surface increased, resulting in a decrease in the protein throughput.
[0107]
[0108] The porous membrane according to the present invention has a high filtration throughput of antibody-containing liquid due to the hydrophobic interaction of the antibody, and is a membrane with excellent virus removal performance, and therefore is suitable for industrial use.
[0109] 500 Outline 501 Circle 502 Outline 505 An example of a hole present on the outer surface of a porous membrane
Claims
1. A porous membrane containing a hydrophobic polymer and a water-insoluble hydrophilic polymer, wherein the pore size / fiber size on the outer surface of the porous membrane is 0.15 or more and 0.26 or less, the long axis / short axis of a circumscribing rectangle of a hole on the outer surface of the porous membrane is 1.00 or more and 1.60 or less, the porous membrane has a dense layer, the proportion of pores of 10 nm or less in the dense layer is 8.0% or less, and the thickness of the dense layer is 1 to 8 μm.
2. The porous membrane according to claim 1, wherein the water-insoluble hydrophilic polymer is electrically neutral.
3. The porous membrane according to claim 1, wherein the hydrophobic polymer is a polysulfone-based polymer.
4. The porous membrane according to claim 1 or 2, wherein the water-insoluble hydrophilic polymer is a vinyl polymer.
5. The porous membrane according to claim 1, wherein the porous membrane has a gradient structure in which the pore size changes continuously from the outer surface of the porous membrane toward the liquid-contacting surface.
6. The porous membrane according to claim 1 or 5, wherein the gradient index of average pore size from the dense layer to the coarse layer is 0.5 to 12.
0.
7. The porous membrane of claim 1 or 5, wherein the porous membrane is an ultrafiltration membrane.
8. The porous membrane according to claim 1 or 5, which is a virus removal membrane.
9. The porous membrane according to claim 1 or 5, wherein the porous membrane is a hollow fiber membrane or a tubular membrane.
10. A filter comprising the porous membrane of claim 1 or 5.
11. A method for producing a porous membrane, comprising: extruding a membrane-forming stock solution containing a hydrophobic polymer, a good solvent, and a non-solvent from a spinneret; and contacting an outer membrane surface coagulation liquid with the membrane-forming stock solution at the same linear speed as the membrane-forming stock solution extruded from the spinneret and parallel to the extrusion direction of the membrane-forming stock solution.
12. A method for purifying an antibody, comprising: preparing a solution containing an antibody; and filtering the solution using the porous membrane of claim 1 to purify the antibody.
Citation Information
Patent Citations
Filter membrane for physiologically active substance solution
JP4024041B2
Ultrafiltration membrane, and method for manufacturing and using an ultrafiltration membrane.
JP4504963B2
Porous hollow fiber membrane
JP5403444B1
porous hollow fiber membrane
JP6367977B2
Porous membrane
JP6385444B2
Cited By
Porous membrane, method for producing same , and method for removing virus
WO2026100705A1
